Keratoconus

First Bowman Layer Transplant for Keratoconus Performed at Southwest Eye Institute

Retrieved on: 
Giovedì, Giugno 4, 2020
Medicine, Medical specialties, Ophthalmology, Eye surgery, Keratoconus, RTT, Corneal transplantation, El Paso, Texas, Bowman's membrane

EL PASO, Texas, June 4, 2020 /PRNewswire-PRWeb/ --Dr. Ahmed Soliman of the Southwest Eye Institute in El Paso, Texas recently performed the first Bowman layer transplant for keratoconus in the state of Texas, making the Southwest Eye Institute only the second center in the entire United States to offer the groundbreaking procedure, which is a minimally invasive, suture-less alternative to full corneal transplant surgery.

Key Points: 
  • EL PASO, Texas, June 4, 2020 /PRNewswire-PRWeb/ --Dr. Ahmed Soliman of the Southwest Eye Institute in El Paso, Texas recently performed the first Bowman layer transplant for keratoconus in the state of Texas, making the Southwest Eye Institute only the second center in the entire United States to offer the groundbreaking procedure, which is a minimally invasive, suture-less alternative to full corneal transplant surgery.
  • Besides Bowman layer transplants, Dr. Soliman and his team at the Southwest Eye Institute offer collagen crosslinking which often stops the progression of the disease, but typically needs to be performed before the corneal changes become too advanced.
  • Dr. Soliman can be reached at the Southwest Eye Institute in El Paso, Texas by phone at (915) 267-2020 or by email [email protected] .
  • About Southwest Eye Institute: The Southwest Eye Institute is the largest and most comprehensive group of eye specialists in the El Paso, Texas area.

Mediaplanet Teams up with Healthcare Professionals to Increase Awareness of Treatment Options for Vision and Hearing Conditions

Retrieved on: 
Giovedì, Marzo 26, 2020
RTT, Audiology, Occupational safety and health, Organ systems, Health, Medicine, Deafness, Hearing loss, Otorhinolaryngology, Tinnitus, Keratoconus, Ear

NEW YORK, March 26, 2020 /PRNewswire-PRWeb/ --Mediaplanet today announces the launch of this year's edition of the "Vision and Hearing Health" publication.

Key Points: 
  • NEW YORK, March 26, 2020 /PRNewswire-PRWeb/ --Mediaplanet today announces the launch of this year's edition of the "Vision and Hearing Health" publication.
  • Most people are unaware of the concerns of early stages of vision and hearing loss that can result in significant damage.
  • These types of disabilities can include keratoconus, thyroid eye disease, significant hearing loss, tinnitus and cochlear damage in which can all lead to a lack of quality of life.
  • He recalled thinking, "I'm definitely [going to] start hitting the ball better when I get my vision right."

Avellino Labs Announces Availability of New FDA-Recognized Genetic Test for Coronavirus

Retrieved on: 
Lunedì, Marzo 9, 2020
Research, Other Health, General Health, Infectious diseases, Hospitals, Genetics, Science, Biotechnology, Nursing, Medical Supplies, FDA, Health, Other Science, Viruses, Medicine, Branches of biology, Coronaviridae, Zoonoses, Animal virology, Severe acute respiratory syndrome-related coronavirus, Coronavirus, Severe acute respiratory syndrome, Genetic testing, Keratoconus, CoV

The Avellino coronavirus test is called the Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2 for short).

Key Points: 
  • The Avellino coronavirus test is called the Avellino SARS-CoV-2/COVID-19 Test (AvellinoCoV2 for short).
  • As developed by Avellinos Chief Laboratory Officer, Connie Chao Shern, PhD, the AvellinoCoV2 patent pending test identifies two genetic factors that test the SARS-CoV-2 virus expression.
  • Therefore, a genetic test such as the AvellinoCoV2 test provides clinicians and public health officials with a valuable diagnostic tool.
  • Beyond the Avellino CoV2 test, Avellino is expanding its diagnostics capabilities with the recent launch of AvaGen, the worlds first DNA test to confirm the presence of genetic indicators that are positively associated with corneal dystrophies and keratoconus genetic risk factors.

Global Keratoconus Pipeline Insight Report 2019: Pipeline Development, Commercial Assessment, Therapeutics, Technologies, Key Companies - ResearchAndMarkets.com

Retrieved on: 
Lunedì, Ottobre 21, 2019
Pharmaceutical, Health, Optical, Keratoconus, RTT

Keratoconus - Pipeline Insight, 2019 report outlays comprehensive insights of present scenario and growth prospects across the indication.

Key Points: 
  • Keratoconus - Pipeline Insight, 2019 report outlays comprehensive insights of present scenario and growth prospects across the indication.
  • A detailed picture of the Keratoconus pipeline landscape is provided which includes the disease overview and Keratoconus treatment guidelines.
  • The assessment part of the report embraces in depth Keratoconus commercial assessment and clinical assessment of the pipeline products under development.
  • It also analyses key players involved in Keratoconus targeted therapeutics development with respective active and dormant or discontinued projects.

Avellino Labs Receives CLIA Certification for Its AvaGen Genetic Diagnostic Test for Keratoconus and Corneal Dystrophies

Retrieved on: 
Lunedì, Ottobre 14, 2019
Biotechnology, Genetics, Optical, Health, Medicine, Health, Clinical medicine, Keratoconus, RTT, Clinical Laboratory Improvement Amendments, Genetic testing, Biotechnology, Genetics, Optical, Health, Medicine, Health, Clinical medicine, Keratoconus, RTT, Clinical Laboratory Improvement Amendments, Genetic testing

Avellino Labs, global biotechnology and genetic science innovators, announced today the company received Clinical Laboratory Improvement Amendments (CLIA) for its AvaGen product, the first genetic test for determining risk of keratoconus and the presence of corneal dystrophies.

Key Points: 
  • Avellino Labs, global biotechnology and genetic science innovators, announced today the company received Clinical Laboratory Improvement Amendments (CLIA) for its AvaGen product, the first genetic test for determining risk of keratoconus and the presence of corneal dystrophies.
  • With CLIA certification of the Avellino Labs Menlo Park facility, effective immediately, the company now is able to receive and analyze patient samples with the novel AvaGen diagnostic tool for the identification of genetic risk factors associated with keratoconus and a variety of corneal dystrophies.
  • AvaGen is the first commercially available genetic diagnostic test of its kind for keratoconus and corneal dystrophies.
  • Utilizing state-of-science CRISPR technology, AvaGen examines over 1,000 variants across 75 genes for keratoconus and over 70 mutations of the TGFBI gene for corneal dystrophies.

Avedro Announces Schedule of Events at the American Academy of Ophthalmology Annual Meeting

Retrieved on: 
Mercoledì, Ottobre 9, 2019
Ophthalmology, Medicine, Medical specialties, Eye surgery, Corneal collagen cross-linking, Keratoconus, Cross-linking, Corneal ectatic disorders, Farhad Hafezi

(Nasdaq: AVDR) (Avedro) today announced its schedule of scientific and educational programs focused on corneal cross-linking and keratoconus during AAO 2019 , the American Academy of Ophthalmologys (AAO) 123rd annual meeting that is being held October 11-15 in San Francisco, CA.

Key Points: 
  • (Nasdaq: AVDR) (Avedro) today announced its schedule of scientific and educational programs focused on corneal cross-linking and keratoconus during AAO 2019 , the American Academy of Ophthalmologys (AAO) 123rd annual meeting that is being held October 11-15 in San Francisco, CA.
  • Avedros presentations and educational events underscore the clinical communitys growing interest in the diagnosis and treatment of keratoconus .
  • Avedros corneal cross-linking treatment is becoming well-established as the only approved therapeutic treatment of progressive keratoconus.
  • We also look forward to discussing exciting new ways in which cross-linking may be applied in the future.

ZEISS Receives FDA Clearance for Epithelial Thickness Mapping for CIRRUS HD-OCT, Enabling More Detailed Assessment of Refractive Surgery Patients

Retrieved on: 
Venerdì, Marzo 8, 2019
Eye surgery, Medicine, Ophthalmology, Medical specialties, RTT, Refraction, Refractive surgery, Keratoconus, Corneal collagen cross-linking, LASIK

"With CIRRUS' Epithelial Thickness Mapping, I can now better identify eligible patients for refractive surgery, and I can also monitor the cornea's post-surgical healing response," Doane said.

Key Points: 
  • "With CIRRUS' Epithelial Thickness Mapping, I can now better identify eligible patients for refractive surgery, and I can also monitor the cornea's post-surgical healing response," Doane said.
  • ETM with CIRRUS provides a detailed nine-millimeter map of epithelial thickness that enables more thorough assessment of patients before refractive surgery, allows monitoring of the cornea's response to treatment, and aids in managing patients with ocular surface disorders such as dry eye and progressive corneal diseases such as keratoconus.
  • With ETM, patients can expect a quick, comfortable non-contact exam that takes less than 1-second.
  • 59 percent are held by Carl Zeiss AG, one of the world's leading groups in the optical and optoelectronic industries.

Ophthalmic Diagnostic Equipment - Medical Devices Pipeline Assessment, 2019 - ResearchAndMarkets.com

Retrieved on: 
Venerdì, Febbraio 22, 2019
Health, Medical devices, Optical, Eye surgery, Corneal collagen cross-linking, Keratoconus, Cross-linking

6.9 Jun 18, 2018: Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus

Key Points: 
  • 6.9 Jun 18, 2018: Avedro Announces Enrollment of First Patient in U.S. Pivotal Phase 3 Epi-on Corneal Cross-Linking Trial for Progressive Keratoconus
    6.10 Jun 14, 2018: The Core DNA of SPECTRALIS: Upgradable platform
    View source version on businesswire.com: https://www.businesswire.com/news/home/20190222005403/en/

Beverly Hills Eye Surgeon, Dr. Brian Boxer Wachler, Launches First Ever Supplement for KeratoconusPatients, KC Defense

Retrieved on: 
Martedì, Febbraio 19, 2019
Medicine, Medical specialties, Eye surgery, Clinical medicine, Keratoconus, RTT, Corneal collagen cross-linking, Corneal transplantation, Cross-linking

BEVERLY HILLS, Calif., Feb. 19, 2019 /PRNewswire-PRWeb/ -- Renowned eye surgeon and founder of the Boxer Wachler Vision Institute, Brian Boxer Wachler, MD, has launched the first ever supplement to help support Keratoconus cornea health.

Key Points: 
  • BEVERLY HILLS, Calif., Feb. 19, 2019 /PRNewswire-PRWeb/ -- Renowned eye surgeon and founder of the Boxer Wachler Vision Institute, Brian Boxer Wachler, MD, has launched the first ever supplement to help support Keratoconus cornea health.
  • The supplement, KC Defense, includes specific amounts Copper (Cu) and Selenium (Se), elements that have been scientifically provento be significantly lower in patients with advanced Keratoconus compared to those without the disease.
  • Dr. Brian Boxer Wachler is known world-wide for developing in 2003 the first ever non-invasive cross-linking procedure to treat Keratoconus, the Holcomb C3-R.
  • Prior to Dr. Boxer Wachler's medical advancements, the most commonly performed procedure for Keratoconus was a painful and invasive cornea transplant.